RNU6-966P

Across TCGA pan-cancer cohorts, RNU6-966P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-966P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-966P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-966P expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

STAD, TGCT, and SKCM are the cancer types where RNU6-966P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
SKCM	OS	Tertile	All	0.283	0.787	.014	9	view →
KIRC	DFS	Tertile	All	1.000	0.617	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-966P–STAD (DFS)

Open the STAD breakdown →